NCT02192268

Brief Summary

The hypothesis of this study is that the physiologic effects of these (PEP/ HFOO) resources may have positive effects in this population of children with acute respiratory illness. Thinking about this physical and physiological issue and due to the absence of a study that has evaluated the effectiveness of these instruments in patients with pneumonia, the objective of this study is to evaluate the short-term effects OOAF and mask of EPAP in children hospitalized for community-acquired pneumonia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 11, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 16, 2014

Completed
3 years until next milestone

Study Start

First participant enrolled

August 1, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
Last Updated

February 24, 2017

Status Verified

February 1, 2017

Enrollment Period

4 months

First QC Date

July 11, 2014

Last Update Submit

February 22, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Severity Score

    Will be assigned a severity score proposed based on other studies with clinical variables and diagnostic criteria. This score will vary from 0 to 18 points. Participants will be followed for the duration of hospital stay, an expected average of 4 or 5 days.

    Change from Baseline Severity score at 4 days

Secondary Outcomes (1)

  • Change in Peak Flow meter

    Change from Baseline peak flow at 4 days

Study Arms (3)

HFOO

ACTIVE COMPARATOR

Children of the HFOO group will be subjected to two daily sessions of this resource which should be the same throughout her hospitalization with Shaker equipment.

Other: HFOO

Assisted Coughing

ACTIVE COMPARATOR

The children in the control group will be subjected to two daily sessions of assisted coughing.

Other: Assisted Coughing

PEP

ACTIVE COMPARATOR

The children will be subjected to PEP group two daily sessions of this resource which should be the same throughout her hospitalization with facial mask and valve Spring load with expiratory pressure of 10cmH2O.

Other: PEP

Interventions

PEPOTHER
PEP
HFOOOTHER
HFOO
Assisted Coughing

Eligibility Criteria

Age3 Years - 11 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • age between 03 and 11 years old;
  • have Pneumonia diagnosis done by a physician pediatrician (1) presence of cough and/or fever; (2) tachypnea according to age group (1-5 years-40 bpm; 5 years -30 bpm); (3) radiological change with consolidation or infiltrators associated or not with other findings compatible with pneumonia. All films will be evaluated by a radiologist and a pediatrician

You may not qualify if:

  • chronic neurological Disease, or respiratory arrest
  • failure to collaborate with therapy or assessment
  • need of invasive or non-invasive ventilatory assistance
  • hemodynamic instability
  • vomiting or nausea
  • not drained Pneumothorax
  • not drained extensive pleural effusion
  • dyspnea
  • do not agree with research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital são Luiz Jabaquara

São Paulo, São Paulo, Brazil

Location

MeSH Terms

Conditions

Pneumonia

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Evelim FD Gomes, PhD

    University of Nove de Julho

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Evelim LFD Gomes, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

July 11, 2014

First Posted

July 16, 2014

Study Start

August 1, 2017

Primary Completion

December 1, 2017

Study Completion

January 1, 2018

Last Updated

February 24, 2017

Record last verified: 2017-02

Locations